83_FR_2819 83 FR 2806 - National Cancer Institute Amended Notice of Meeting

83 FR 2806 - National Cancer Institute Amended Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 83, Issue 13 (January 19, 2018)

Page Range2806-2807
FR Document2018-00872

Federal Register, Volume 83 Issue 13 (Friday, January 19, 2018) 
[Federal Register Volume 83, Number 13 (Friday, January 19, 2018)]
[Notices]
[Pages 2806-2807]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-00872]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Institute Special Emphasis Panel, February 08, 2018, 09:00 a.m. 
to February 08, 2018, 04:00 p.m., National Cancer Institute Shady 
Grove, 9609 Medical Center Drive, Rockville, MD 20850 which was 
published in the Federal Register on December 27, 2017, 82 FR 61309.
    This meeting notice is amended to change the meeting title from 
``Cancer Cachexia Therapy and Local Delivery of Chemopreventive 
Agents'' to ``TEP-9A: Local Delivery of Chemopreventive

[[Page 2807]]

Agents for Cancer''. The meeting is closed to the public.

    Dated: January 9, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-00872 Filed 1-18-18; 8:45 am]
 BILLING CODE 4140-01-P

2806 Federal Register / Vol. 83, No. 13 / Friday, January 19, 2018 / Notices Contact Person: Jin Huang, Ph.D., Date: February 15–16, 2018. MSC 7814, Bethesda, MD 20892–7814, 301– Scientific Review Officer, Center for Time: 8:00 a.m. to 4:00 p.m. 435–1260, borzanj@csr.nih.gov. Scientific Review, National Institutes of Agenda: To review and evaluate grant Name of Committee: Endocrinology, Health, 6701 Rockledge Drive, Room 4199, applications. Metabolism, Nutrition and Reproductive MSC 7812, Bethesda, MD 20892, 301–435– Place: The Darcy Hotel, 1515 Rhode Island Sciences Integrated Review Group; 1230, jh377p@nih.gov. Ave. NW, Washington, DC 20005. Integrative and Clinical Endocrinology and Name of Committee: Endocrinology, Contact Person: Christine A Piggee, Ph.D., Reproduction Study Section. Metabolism, Nutrition and Reproductive Scientific Review Officer, Center for Date: February 15, 2018. Sciences Integrated Review Group; Molecular Scientific Review, National Institutes of Time: 8:00 a.m. to 6:00 p.m. and Cellular Endocrinology Study Section. Health, 6701 Rockledge Drive, Room 4186, Agenda: To review and evaluate grant Date: February 8–9, 2018. MSC 7850, Bethesda, MD 20892, 301–435– applications. Time: 8:00 a.m. to 5:00 p.m. 0657, christine.piggee@nih.gov. Place: Embassy Suites by Hilton, Denver Agenda: To review and evaluate grant Name of Committee: Molecular, Cellular Intl. Airport, 7001 Yampa St., Denver, CO applications. and Developmental Neuroscience Integrated 80249. Place: Ritz-Carlton Hotel at Pentagon City, Review Group; Neurotransporters, Receptors, Contact Person: Dianne Hardy, Ph.D., 1250 South Hayes Street, Arlington, VA and Calcium Signaling Study Section. Scientific Review Officer, Center for 22202. Date: February 15–16, 2018. Scientific Review, National Institutes of Contact Person: Liliana Norma Berti- Time: 8:00 a.m. to 1:00 p.m. Health, 6701 Rockledge Drive, Room 6175, Mattera, Ph.D., Scientific Review Officer, Agenda: To review and evaluate grant MSC 7892, Bethesda, MD 20892, 301–435– Center for Scientific Review, National applications. 1154, dianne.hardy@nih.gov. Institutes of Health, 6701 Rockledge Drive, Place: Serrano Hotel, 405 Taylor Street, Name of Committee: Cell Biology RM 4215, Bethesda, MD 20892, liliana.berti- San Francisco, CA 94102. Integrated Review Group; Cellular mattera@nih.gov. Contact Person: Peter B Guthrie, Ph.D., Mechanisms in Aging and Development Name of Committee: Center for Scientific Scientific Review Officer, Center for Study Section. Review Special Emphasis Panel; Nursing and Scientific Review, National Institutes of Date: February 15–16, 2018. Related Clinical Sciences. Health, 6701 Rockledge Drive, Room 4182, Time: 8:00 a.m. to 6:00 p.m. Date: February 8–9, 2018. MSC 7850, Bethesda, MD 20892, (301) 435– Agenda: To review and evaluate grant Time: 8:00 a.m. to 6:00 p.m. 1239, guthriep@csr.nih.gov. applications. Agenda: To review and evaluate grant Name of Committee: Oncology 1-Basic Place: The Westin St. Francis, 335 Powell applications. Translational Integrated Review Group; Street, San Francisco, CA 94102. Place: Hyatt Regency Bethesda, One Tumor Cell Biology Study Section. Contact Person: John Burch, Ph.D., Bethesda Metro Center, 7400 Wisconsin Scientific Review Officer, Center for Date: February 15–16, 2018. Avenue, Bethesda, MD 20814. Scientific Review, National Institute of 8:00 a.m. to 5:00 p.m. Contact Person: Martha L Hare, Ph.D., RN, Health, 6701 Rockledge Drive, Room 3213, Agenda: To review and evaluate grant Scientific Review Officer, Center for MSC 7808, Bethesda, MD 20892, 301–408– applications. Scientific Review, National Institutes of 9519, burchjb@csr.nih.gov. Place: Hotel Zoe, 425 North Point St., San Health, 6701 Rockledge Drive, Room 3154, Francisco, CA 94133. (Catalogue of Federal Domestic Assistance Bethesda, MD 20892, (301) 451–8504, Contact Person: Charles Morrow, MD, Program Nos. 93.306, Comparative Medicine; harem@mail.nih.gov. Ph.D., Scientific Review Officer, Center for 93.333, Clinical Research, 93.306, 93.333, Name of Committee: Center for Scientific Scientific Review, National Institutes of 93.337, 93.393–93.396, 93.837–93.844, Review Special Emphasis Panel; PAR Panel: Health, 6701 Rockledge Drive, Room 6202, 93.846–93.878, 93.892, 93.893, National Biophysical and Biomechanical Aspects of MSC 7804, Bethesda, MD 20892, 301–408– Institutes of Health, HHS) Embryonic Development. 9850. morrowcs@csr.nih.gov. Dated: January 11, 2018. Date: February 14, 2018. Name of Committee: Population Sciences David Clary, Time: 7:00 a.m. to 1:00 p.m. and Epidemiology Integrated Review Group; Program Analyst, Office of Federal Advisory Agenda: To review and evaluate grant Social Sciences and Population Studies B Committee Policy. applications. Study Section. Place: Sir Francis Drake Hotel, 450 Powell [FR Doc. 2018–00870 Filed 1–18–18; 8:45 am] Date: February 15, 2018. Street at Sutter, San Francisco, CA 94102. Time: 8:00 a.m. to 6:00 p.m. BILLING CODE 4140–01–P Contact Person: Thomas Beres, Ph.D., Agenda: To review and evaluate grant Scientific Review Officer, Center for applications. Scientific Review, National Institutes of Place: Sheraton Delfina Santa Monica DEPARTMENT OF HEALTH AND Health, 6701 Rockledge Drive, Rm. 5201, Hotel, 530 West Pico Boulevard, Santa HUMAN SERVICES MSC 7840, Bethesda, MD 20892, 301–435– Monica, CA 90405. 1175, berestm@mail.nih.gov. Contact Person: Kate Fothergill, Ph.D., National Institutes of Health Name of Committee: Brain Disorders and Scientific Review Officer, Center for Clinical Neuroscience Integrated Review Scientific Review, National Institutes of National Cancer Institute Amended Group; Chronic Dysfunction and Integrative Health, 6701 Rockledge Drive, Room 3142, Notice of Meeting Neurodegeneration Study Section. Bethesda, MD 20892, 301–435–2309, Date: February 15–16, 2018. fothergillke@mail.nih.gov. Notice is hereby given of a change in Time: 8:00 a.m. to 5:00 p.m. Name of Committee: Integrative, the meeting of the National Cancer Agenda: To review and evaluate grant Functional and Cognitive Neuroscience Institute Special Emphasis Panel, applications. Integrated Review Group; Neurobiology of February 08, 2018, 09:00 a.m. to Place: New Orleans Marriott, 555 Canal Motivated Behavior Study Section. February 08, 2018, 04:00 p.m., National Street, New Orleans, LA 70130. Date: February 15–16, 2018. Cancer Institute Shady Grove, 9609 Contact Person: Alexei Kondratyev, Ph.D., Time: 8:00 a.m. to 6:00 p.m. Medical Center Drive, Rockville, MD Scientific Review Officer, Center for Agenda: To review and evaluate grant 20850 which was published in the daltland on DSKBBV9HB2PROD with NOTICES Scientific Review, National Institutes of applications. Health, 6701 Rockledge Drive, Room 5200, Federal Register on December 27, 2017, Place: Embassy Suites DC Convention MSC 7846, Bethesda, MD 20892, 301–435– Center, 900 10th Street NW, Washington, DC 82 FR 61309. 1785, kondratyevad@csr.nih.gov. 20001. This meeting notice is amended to Name of Committee: Molecular, Cellular Contact Person: Jasenka Borzan, Ph.D., change the meeting title from ‘‘Cancer and Developmental Neuroscience Integrated Scientific Review Officer, Center for Cachexia Therapy and Local Delivery of Review Group; Synapses, Cytoskeleton and Scientific Review, National Institutes of Chemopreventive Agents’’ to ‘‘TEP–9A: Trafficking Study Section. Health, 6701 Rockledge Drive, Room 4214 Local Delivery of Chemopreventive VerDate Sep<11>2014 17:05 Jan 18, 2018 Jkt 244001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 E:\FR\FM\19JAN1.SGM 19JAN1

Federal Register / Vol. 83, No. 13 / Friday, January 19, 2018 / Notices 2807 Agents for Cancer’’. The meeting is Dated: January 11, 2018. DEPARTMENT OF HEALTH AND closed to the public. Melanie J. Pantoja, HUMAN SERVICES Dated: January 9, 2018. Program Analyst, Office of Federal Advisory Committee Policy. National Institutes of Health Melanie J. Pantoja, Program Analyst, Office of Federal Advisory [FR Doc. 2018–00862 Filed 1–18–18; 8:45 am] Center for Scientific Review; Notice of Committee Policy. BILLING CODE 4140–01–P Closed Meetings [FR Doc. 2018–00872 Filed 1–18–18; 8:45 am] BILLING CODE 4140–01–P Pursuant to section 10(d) of the DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as HUMAN SERVICES amended, notice is hereby given of the DEPARTMENT OF HEALTH AND following meetings. HUMAN SERVICES National Institutes of Health The meetings will be closed to the public in accordance with the National Institutes of Health National Institute of Allergy and provisions set forth in sections Infectious Diseases; Notice of Closed 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Cancer Institute; Notice of Meeting as amended. The grant applications and Meeting the discussions could disclose Pursuant to section 10(d) of the confidential trade secrets or commercial Pursuant to section 10(a) of the Federal Advisory Committee Act, as property such as patentable material, Federal Advisory Committee Act, as amended, notice is hereby given of a and personal information concerning amended, notice is hereby given of a meeting of the Microbiology, Infectious individuals associated with the grant meeting of the National Cancer Institute Diseases and AIDS Initial Review Group applications, the disclosure of which Clinical Trials and Translational Microbiology and Infectious Diseases B would constitute a clearly unwarranted Research Advisory Committee. Subcommittee. invasion of personal privacy. The meeting will be open to the The meeting will be closed to the Name of Committee: Musculoskeletal, Oral public. The open session will be public as indicated below in accordance and Skin Sciences Integrated Review Group; videocast and can be accessed from the with the provisions set forth in sections Skeletal Muscle and Exercise Physiology NIH Videocasting and Podcasting 552b(c)(6), Title 5 U.S.C., as amended Study Section. website (http://videocast.nih.gov/). for review, discussion, and evaluation of Date: February 8–9, 2018. individual intramural programs and Time: 8:00 a.m. to 6:00 p.m. Name of Committee: National Cancer Agenda: To review and evaluate grant Institute Clinical Trials and Translational projects conducted by the National applications. Research Advisory Committee. Institute of Allergy and Infectious Place: Hilton Long Beach and Executive Date: March 7, 2018. Diseases, including consideration of Center, 701 West Ocean Boulevard, Long Time: 11:00 a.m. to 1:00 p.m. personnel qualifications and Beach, CA 90831. Agenda: Strategic Discussion of NCI’s performance, and the competence of Contact Person: Richard Ingraham, Ph.D., Clinical and Translational Research individual investors, the disclosure of Scientific Review Officer, Center for Programs. which would constitue a clearly Scientific Review, National Institutes of Place: National Institutes of Health, Health, 6701 Rockledge Drive, Room 4116, unwarranted invasion of personal Building 31, Room 11A01, 31 Center Drive, MSC 7814, Bethesda, MD 20892, 301–496– Bethesda, MD 20892 (Virtual Meeting). privacy. 8551, ingrahamrh@mail.nih.gov. Contact Person: Sheila A. Prindiville, MD, Name of Committee: Microbiology, Name of Committee: Population Sciences MPH, Director, Coordinating Center for Infectious Diseases and AIDS Initial Review and Epidemiology Integrated Review Group; Clinical Trials, National Institutes of Health, Group, Microbiology and Infectious Diseases Neurological, Aging and Musculoskeletal National Cancer Institute, Coordinating B Subcommittee MID–B, February 2018. Epidemiology Study Section. Center for Clinical Trials, 9609 Medical Date: February 12–13, 2018. Date: February 8–9, 2018. Center Drive Room 6W136, Rockville, MD Time: 8:00 a.m. to 6:00 p.m. Time: 8:30 a.m. to 6:00 p.m. 20850, 240–276–6173, prindivs@ Agenda: To review and evaluate grant Agenda: To review and evaluate grant mail.nih.gov. applications. applications. Any interested person may file written Place: Bahia Resort Hotel, 3999 West Place: JW Marriott New Orleans, 614 Canal comments with the committee by forwarding Street, New Orleans, LA 70130. Mission Bay Drive, San Diego, CA 92109. the statement to the Contact Person listed on Contact Person: Heidi B. Friedman, Ph.D., Contact Person: Ellen S. Buczko, Ph.D., this notice. The statement should include the Scientific Review Officer, Center for name, address, telephone number and when Scientific Review Officer, Scientific Review Scientific Review, National Institutes of applicable, the business or professional Program, Division of Extramural Activities, Health, 6701 Rockledge Drive, Room 1012A, affiliation of the interested person. National Institutes of Health/NIAID, 6700B MSC 7770, Bethesda, MD 20892, 301–435– Information is also available on the Rockledge Drive, MSC 7616, Bethesda, MD 1721, hfriedman@csr.nih.gov. Institute’s/Center’s home page: http:// 20892–7616, 301–451–2676, ebuczko1@ Name of Committee: Infectious Diseases deainfo.nci.nih.gov/advisory/ctac/ctac.htm, niaid.nih.gov. and Microbiology Integrated Review Group; where an agenda and any additional (Catalogue of Federal Domestic Assistance Host Interactions with Bacterial Pathogens information for the meeting will be posted Program Nos. 93.855, Allergy, Immunology, Study Section. when available. and Transplantation Research; 93.856, Date: February 9, 2018. (Catalogue of Federal Domestic Assistance Microbiology and Infectious Diseases Time: 8:00 a.m. to 6:00 p.m. Program Nos. 93.392, Cancer Construction; Research, National Institutes of Health, HHS) Agenda: To review and evaluate grant daltland on DSKBBV9HB2PROD with NOTICES 93.393, Cancer Cause and Prevention applications. Research; 93.394, Cancer Detection and Dated: January 10, 2018. Place: Hyatt Regency Bethesda, One Diagnosis Research; 93.395, Cancer Natasha M. Copeland, Bethesda Metro Center, 7400 Wisconsin Treatment Research; 93.396, Cancer Biology Avenue, Bethesda, MD 20814. Program Analyst, Office of Federal Advisory Research; 93.397, Cancer Centers Support; Contact Person: Fouad A. El-Zaatari, Ph.D., Committee Policy. 93.398, Cancer Research Manpower; 93.399, Scientific Review Officer, Center for Cancer Control, National Institutes of Health, [FR Doc. 2018–00867 Filed 1–18–18; 8:45 am] Scientific Review, National Institutes of HHS) BILLING CODE 4140–01–P Health, 6701 Rockledge Drive, Room 3186, VerDate Sep<11>2014 17:05 Jan 18, 2018 Jkt 244001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\19JAN1.SGM 19JAN1


Document Created: 2018-01-19 02:42:28
Document Modified: 2018-01-19 02:42:28
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation83 FR 2806 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR